Cargando…
Who prefers what? Correlates of preferences for next‐generation HIV prevention products among a national U.S. sample of young men who have sex with men
INTRODUCTION: Pre‐exposure prophylaxis (PrEP) has been available for young people for over a decade, yet only ∼15% of young people in the United States with indications for PrEP have a prescription for it. Next‐generation PrEP modalities may address some of the challenges of daily oral PrEP. However...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339006/ https://www.ncbi.nlm.nih.gov/pubmed/37439061 http://dx.doi.org/10.1002/jia2.26096 |
_version_ | 1785071755226775552 |
---|---|
author | Biello, Katie B. Valente, Pablo K. da Silva, Daniel Teixeira Lin, Willey Drab, Ryan Hightow‐Weidman, Lisa Mayer, Kenneth H. Bauermeister, José A. |
author_facet | Biello, Katie B. Valente, Pablo K. da Silva, Daniel Teixeira Lin, Willey Drab, Ryan Hightow‐Weidman, Lisa Mayer, Kenneth H. Bauermeister, José A. |
author_sort | Biello, Katie B. |
collection | PubMed |
description | INTRODUCTION: Pre‐exposure prophylaxis (PrEP) has been available for young people for over a decade, yet only ∼15% of young people in the United States with indications for PrEP have a prescription for it. Next‐generation PrEP modalities may address some of the challenges of daily oral PrEP. However, preferences for these products are unknown. METHODS: From October 2020 to June 2021, we conducted an online survey of 737 cisgender, young men who have sex with men (age 15–24 years) without HIV across the United States who reported same‐sex attraction or consensual sex with another man in the past 6 months. Participants completed a conjoint experiment comparing daily oral pills, event‐driven oral pills, event‐driven rectal douches, intramuscular injections, intravenous broadly neutralizing antibody (bnAb) infusions and subcutaneous implants. Participants ranked the products from most to least preferred. Exploded logit models examined the association between ranked preferences of PrEP modalities and socio‐demographic and behavioural characteristics. RESULTS: Participants’ mean age was 21 years (SD = 2.3), and 56% identified as White. Nineteen percent were currently taking daily oral PrEP, and another 9% had previously taken it. Participants prioritized efficacy, absence of side effects and costs in the conjoint analyses. Daily oral PrEP had the highest preference ranking, followed by event‐driven oral (OR = 0.89, p = 0.058), injectable (OR = 0.83, p = 0.005), implant (OR = 0.48, p < 0.0001), bnAb infusions (OR = 0.38, p < 0.0001) and rectal douches (OR = 0.24, p < 0.0001). There were differences in PrEP preferences across age, insurance status, sexual behaviour, PrEP use history, HIV and sexually transmitted infection (STI) testing history, and STI diagnoses (omnibus tests: p < 0.05). Participants also provided reasons for selecting their top product choice: ease of use for those who chose daily oral (99%) and daily event‐driven (98.5%); feel more protected against HIV for those who chose injectable (95.4%) and implants (100%); not worrying about forgetting to take it for those who chose bnAbs (93.8%); and being able to stop taking it when they want for those who chose rectal douche (90.9%). CONCLUSIONS: Next‐generation modalities were less likely to be preferred over daily oral PrEP, with differences in the magnitude by socio‐demographic and behavioural characteristics. Given the low uptake of daily oral PrEP, end‐users’ preferences for and concerns about PrEP products must be understood to ensure high acceptability and penetration. |
format | Online Article Text |
id | pubmed-10339006 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103390062023-07-14 Who prefers what? Correlates of preferences for next‐generation HIV prevention products among a national U.S. sample of young men who have sex with men Biello, Katie B. Valente, Pablo K. da Silva, Daniel Teixeira Lin, Willey Drab, Ryan Hightow‐Weidman, Lisa Mayer, Kenneth H. Bauermeister, José A. J Int AIDS Soc Research Articles INTRODUCTION: Pre‐exposure prophylaxis (PrEP) has been available for young people for over a decade, yet only ∼15% of young people in the United States with indications for PrEP have a prescription for it. Next‐generation PrEP modalities may address some of the challenges of daily oral PrEP. However, preferences for these products are unknown. METHODS: From October 2020 to June 2021, we conducted an online survey of 737 cisgender, young men who have sex with men (age 15–24 years) without HIV across the United States who reported same‐sex attraction or consensual sex with another man in the past 6 months. Participants completed a conjoint experiment comparing daily oral pills, event‐driven oral pills, event‐driven rectal douches, intramuscular injections, intravenous broadly neutralizing antibody (bnAb) infusions and subcutaneous implants. Participants ranked the products from most to least preferred. Exploded logit models examined the association between ranked preferences of PrEP modalities and socio‐demographic and behavioural characteristics. RESULTS: Participants’ mean age was 21 years (SD = 2.3), and 56% identified as White. Nineteen percent were currently taking daily oral PrEP, and another 9% had previously taken it. Participants prioritized efficacy, absence of side effects and costs in the conjoint analyses. Daily oral PrEP had the highest preference ranking, followed by event‐driven oral (OR = 0.89, p = 0.058), injectable (OR = 0.83, p = 0.005), implant (OR = 0.48, p < 0.0001), bnAb infusions (OR = 0.38, p < 0.0001) and rectal douches (OR = 0.24, p < 0.0001). There were differences in PrEP preferences across age, insurance status, sexual behaviour, PrEP use history, HIV and sexually transmitted infection (STI) testing history, and STI diagnoses (omnibus tests: p < 0.05). Participants also provided reasons for selecting their top product choice: ease of use for those who chose daily oral (99%) and daily event‐driven (98.5%); feel more protected against HIV for those who chose injectable (95.4%) and implants (100%); not worrying about forgetting to take it for those who chose bnAbs (93.8%); and being able to stop taking it when they want for those who chose rectal douche (90.9%). CONCLUSIONS: Next‐generation modalities were less likely to be preferred over daily oral PrEP, with differences in the magnitude by socio‐demographic and behavioural characteristics. Given the low uptake of daily oral PrEP, end‐users’ preferences for and concerns about PrEP products must be understood to ensure high acceptability and penetration. John Wiley and Sons Inc. 2023-07-13 /pmc/articles/PMC10339006/ /pubmed/37439061 http://dx.doi.org/10.1002/jia2.26096 Text en © 2023 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Biello, Katie B. Valente, Pablo K. da Silva, Daniel Teixeira Lin, Willey Drab, Ryan Hightow‐Weidman, Lisa Mayer, Kenneth H. Bauermeister, José A. Who prefers what? Correlates of preferences for next‐generation HIV prevention products among a national U.S. sample of young men who have sex with men |
title | Who prefers what? Correlates of preferences for next‐generation HIV prevention products among a national U.S. sample of young men who have sex with men |
title_full | Who prefers what? Correlates of preferences for next‐generation HIV prevention products among a national U.S. sample of young men who have sex with men |
title_fullStr | Who prefers what? Correlates of preferences for next‐generation HIV prevention products among a national U.S. sample of young men who have sex with men |
title_full_unstemmed | Who prefers what? Correlates of preferences for next‐generation HIV prevention products among a national U.S. sample of young men who have sex with men |
title_short | Who prefers what? Correlates of preferences for next‐generation HIV prevention products among a national U.S. sample of young men who have sex with men |
title_sort | who prefers what? correlates of preferences for next‐generation hiv prevention products among a national u.s. sample of young men who have sex with men |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339006/ https://www.ncbi.nlm.nih.gov/pubmed/37439061 http://dx.doi.org/10.1002/jia2.26096 |
work_keys_str_mv | AT biellokatieb whopreferswhatcorrelatesofpreferencesfornextgenerationhivpreventionproductsamonganationalussampleofyoungmenwhohavesexwithmen AT valentepablok whopreferswhatcorrelatesofpreferencesfornextgenerationhivpreventionproductsamonganationalussampleofyoungmenwhohavesexwithmen AT dasilvadanielteixeira whopreferswhatcorrelatesofpreferencesfornextgenerationhivpreventionproductsamonganationalussampleofyoungmenwhohavesexwithmen AT linwilley whopreferswhatcorrelatesofpreferencesfornextgenerationhivpreventionproductsamonganationalussampleofyoungmenwhohavesexwithmen AT drabryan whopreferswhatcorrelatesofpreferencesfornextgenerationhivpreventionproductsamonganationalussampleofyoungmenwhohavesexwithmen AT hightowweidmanlisa whopreferswhatcorrelatesofpreferencesfornextgenerationhivpreventionproductsamonganationalussampleofyoungmenwhohavesexwithmen AT mayerkennethh whopreferswhatcorrelatesofpreferencesfornextgenerationhivpreventionproductsamonganationalussampleofyoungmenwhohavesexwithmen AT bauermeisterjosea whopreferswhatcorrelatesofpreferencesfornextgenerationhivpreventionproductsamonganationalussampleofyoungmenwhohavesexwithmen AT whopreferswhatcorrelatesofpreferencesfornextgenerationhivpreventionproductsamonganationalussampleofyoungmenwhohavesexwithmen |